Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose intradermal versus intramuscular Inflexal V influenza vaccine study
ISRCTN33950739Phase 2Completed
- Sponsor
- Berna Biotech AG
- Start
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of Inflexal V in influenza (2 arms), sponsored by Berna Biotech AG. Primary endpoint: Immunogenicity. Started Sep 2007; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN33950739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN33950739.